Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

ANKRD20A5 Inhibitors

ANKRD20A5 inhibitors are a specialized class of compounds designed to target the ANKRD20A5 protein, which contains ankyrin repeat domains responsible for mediating protein-protein interactions. ANKRD20A5 is part of the larger ankyrin repeat domain-containing protein family, known for their role in facilitating structural and functional assemblies within cellular processes. These ankyrin repeat domains form a characteristic array of helix-loop-helix structures that create specific binding interfaces for interacting with other proteins. ANKRD20A5 inhibitors work by disrupting these key interactions, preventing ANKRD20A5 from effectively participating in the formation of multi-protein complexes. This interference can alter the regulation of various cellular pathways, as ANKRD20A5 plays a role in maintaining the integrity of certain molecular assemblies.

Chemically, ANKRD20A5 inhibitors display considerable structural diversity, reflecting the need to target specific binding regions within the ankyrin repeat domains. These inhibitors may consist of small organic molecules, synthetic peptides, or even larger biologics that are designed to fit within the unique pockets or surfaces formed by the ankyrin repeats. Some inhibitors act by mimicking the natural ligands or interacting partners of ANKRD20A5, competitively binding to these critical interfaces and blocking access to the natural binding sites. Others may induce structural changes in ANKRD20A5, destabilizing the ankyrin repeat scaffold and preventing the protein from maintaining its functional conformation. By modulating the interactions mediated by ANKRD20A5, these inhibitors provide a valuable approach to understanding the protein's role in cellular organization and its involvement in various intracellular processes.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound inhibits DNA methyltransferases, potentially reducing methylation and altering gene expression patterns.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

As a histone deacetylase inhibitor, it can increase histone acetylation and affect gene transcription.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

This DNA methyltransferase inhibitor might lead to hypomethylation of gene promoters.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

It inhibits histone deacetylases, potentially causing changes in gene expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

It binds to DNA and inhibits transcription factors, which may reduce gene expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Similar to 5-Azacytidine, it inhibits DNA methylation, affecting gene expression.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

As a histone deacetylase inhibitor, it may affect chromatin structure and gene expression.

ACY-1215

1316214-52-4sc-507455
25 mg
$110.00
(0)

This compound targets histone deacetylases, potentially impacting gene transcription.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

It is a broad histone deacetylase inhibitor that could influence gene expression patterns.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

This histone deacetylase inhibitor could alter chromatin structure and gene expression.